REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 10th, 2015 • BioScrip, Inc. • Retail-drug stores and proprietary stores • New York
Contract Type FiledMarch 10th, 2015 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of March 9, 2015, by and among BioScrip, Inc., a Delaware corporation (the “Company”), Coliseum Capital Partners, L.P., a Delaware limited partnership, Coliseum Capital Partners II, L.P., a Delaware limited partnership and Blackwell Partners, LLC, Series A, a Georgia limited liability company (each a “Stockholder” and collectively, the “Stockholders”). Each of the Company and the Stockholders may be referred to in this Agreement as a “Party,” and, collectively, as the “Parties.” Capitalized terms used but not otherwise defined herein have the meanings assigned such terms in Section 9 of this Agreement.
BIOSCRIP, INC. WARRANT AGREEMENT Dated As Of March 9, 2015 Warrants to Purchase 3,600,000 shares of Common StockWarrant Agreement • March 10th, 2015 • BioScrip, Inc. • Retail-drug stores and proprietary stores • Delaware
Contract Type FiledMarch 10th, 2015 Company Industry JurisdictionWARRANT AGREEMENT, dated as of March 9, 2015, among BioScrip, Inc., a Delaware corporation (together with its successors and assigns, the “Company”), Coliseum Capital Partners, L.P., a Delaware limited partnership, Coliseum Capital Partners II, L.P., a Delaware limited partnership, and Blackwell Partners, LLC, Series A, a Georgia limited liability company (collectively and together with each of their respective successors and assigns, the “Purchasers”). Capitalized terms shall have the meaning specified in Section 5.1 hereof.
SECURITIES PURCHASE AGREEMENT between BIOSCRIP, INC. and THE INVESTORS NAMED HEREIN Dated March 9, 2015Securities Purchase Agreement • March 10th, 2015 • BioScrip, Inc. • Retail-drug stores and proprietary stores • New York
Contract Type FiledMarch 10th, 2015 Company Industry JurisdictionTHIS SECURITIES PURCHASE AGREEMENT dated as of March 9, 2015 (this “Agreement”), by and among BioScrip, Inc., a Delaware corporation (the “Company”), Coliseum Capital Partners, L.P., a Delaware limited partnership, Coliseum Capital Partners II, L.P., a Delaware limited partnership, and Blackwell Partners, LLC, Series A, a Georgia limited liability company (each, an “Investor”) and collectively the “Investors”).